The US Centers for Disease Control and Prevention (CDC) and the US Food and Drug Administration (FDA) have recommended that the US pause the use of Johnson & Johnson's COVID-19 vaccine because of six reported US cases of a rare and severe type of blood clot, CNN news company reported on Tuesday.
According to European health authorities, there have been "four serious cases of unusual blood clots" reported in people who were given the Johnson & Johnson vaccine and like their US counterparts, the European authorities are investigating these cases and that "it is currently not clear" whether there's a causal association between the vaccine and the clots, CNN added.
US health officials are encouraging Americans to get vaccinated as soon as they can, however there are concerns that news coverage about clots being studied in relation to Johnson & Johnson's vaccine might make some Americans more hesitant to get vaccinated for COVID-19.
Virbac expands presence in Japan with Sasaeah acquisition
Pfizer reveals strong efficacy data for ABRYSVO in older adults against RSV
US CDC advisory committee backs Valneva's chikungunya vaccine
Takeda and Biological E. Limited join forces to combat global dengue threat
SK bioscience 'SKYTyphoid' receives WHO prequalification certification
ImmunityBio advances cancer vaccine trial for Lynch syndrome participants
AstraZeneca boosts vaccine portfolio with acquisition of Icosavax
Ultimovacs gains EMA Orphan Drug status for UV1 cancer vaccine in mesothelioma